These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4398477)

  • 1. Release of noradrenaline from the dog heart in situ after intravenous and intracoronary administration of 5-hydroxytryptamine.
    Fillion GM; Lluch S; Uvnäs B
    Acta Physiol Scand; 1971 Sep; 83(1):115-23. PubMed ID: 4398477
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of noradrenaline from the dog heart in situ following administration of 5-hydroxytryptamine (5-HT).
    Fillion G; Lluch S
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):45. PubMed ID: 5314420
    [No Abstract]   [Full Text] [Related]  

  • 3. [Noradrenaline release from the dog heart following temporary occlusion of a coronary artery].
    Shahab L; Wollenberger A; Haase M; Schiller U
    Acta Biol Med Ger; 1969; 22(1):135-43. PubMed ID: 4391410
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine.
    Vanhoutte PM; Lorenz RR; Tyce GM
    J Pharmacol Exp Ther; 1973 May; 185(2):386-94. PubMed ID: 4703828
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on mechanisms controlling the secretion of neurotransmitters in the rabbit heart.
    Wennmalm A
    Acta Physiol Scand Suppl; 1971; 365():1-36. PubMed ID: 4398036
    [No Abstract]   [Full Text] [Related]  

  • 6. Desipramine-induced release of norepinephrine from heart.
    Leitz FH; Stefano FJ
    Biochem Pharmacol; 1970 May; 19(5):1797-801. PubMed ID: 5513960
    [No Abstract]   [Full Text] [Related]  

  • 7. The stereospecificity of noradrenaline uptake by cat atria.
    Mueller RA; Shideman FE
    J Pharm Pharmacol; 1967 Jun; 19(6):398-400. PubMed ID: 4382371
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of steady-state kinetics to the uptake and decline of H3-NE in the rat heart.
    Neff NH; Tozer TN; Hammer W; Costa E; Brodie BB
    J Pharmacol Exp Ther; 1968 Mar; 160(1):48-52. PubMed ID: 5639110
    [No Abstract]   [Full Text] [Related]  

  • 9. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves.
    Axelrod J; Kopin IJ
    Prog Brain Res; 1969; 31():21-32. PubMed ID: 4900113
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of right ventricular electric stimulation on cardiac dynamics, metabolism and noradrenaline release. Studies in man and anaesthezised sheep].
    Klein WW
    Arch Kreislaufforsch; 1971; 64(1):129-83. PubMed ID: 4397042
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandins and synaptosomal transport of 3 H-norepinephrine and 3 H-5-hydroxytryptamine.
    Ciofalo FR
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):551-4. PubMed ID: 4699482
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholamines associated with conductile and contractile myocardium of normal and denervated dog hearts.
    Spurgeon HA; Priola DV; Montoya P; Weiss GK; Alter WA
    J Pharmacol Exp Ther; 1974 Sep; 190(3):466-71. PubMed ID: 4412348
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
    Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
    Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. 3. Selective increase of norepinephrine in the rat pineal gland consecutive to depletion of neuronal 5-hydroxytryptamine.
    Jaim-Etcheverry G; Zeiher LM
    J Pharmacol Exp Ther; 1971 Jul; 178(1):42-8. PubMed ID: 4253294
    [No Abstract]   [Full Text] [Related]  

  • 17. Facilitation of adrenergic transmission in the canine heart by intracoronary infusion of angiotensin II: effect of prostaglandin synthesis inhibition.
    Lanier SM; Malik KU
    J Pharmacol Exp Ther; 1983 Dec; 227(3):676-82. PubMed ID: 6317843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotic mechanism of decreasing norepinephrine and glycogen in dog myocardium after the coronary artery ligation].
    Sakai K; Abiko Y
    Kokyu To Junkan; 1984 Nov; 32(11):1111-4. PubMed ID: 6151725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of various local anesthetics and metanephrine on the uptake of tritiated noradrenaline uptake by the rat heart].
    Damas J; Thiriet E; Chartry-Trinon J
    C R Seances Soc Biol Fil; 1971; 165(9):2023-6. PubMed ID: 4263147
    [No Abstract]   [Full Text] [Related]  

  • 20. Extent of release and elimination of noradrenaline at peripheral adrenergic nerve terminals.
    Folkow B; Häggendal J; Lisander B
    Acta Physiol Scand Suppl; 1967; 307():1-38. PubMed ID: 4297559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.